Search
for
Sort by
Research 481–510 of 1000+
- Efficacy and safety of combined microneedling therapy for androgenic alopecia: A systematic review and meta‐analysis of randomized clinical trials
- The effect of curcumin supplementation on circulating adiponectin and leptin concentration in adults: a GRADE-assessed systematic review and meta-analysis of randomised controlled trials
- Comparative Efficacy of Topical Minoxidil Alone Against Combination of Topical Minoxidil and Platelet Rich Plasma in Women with Female Pattern Hair Loss-A Pilot, Open Randomised Trial.
- The Effects of Statins on Hyperandrogenism In Women With Polycystic Ovary Syndrome: A Systematic Review And Meta-analysis of Randomized Controlled Trials
- Supplementary Material for: Autologous Cell Therapy for Aged Human Skin: A Randomized, Placebo-Controlled, Phase-I Study
- Enabling finasteride 1 mg users to further improve hair pattern: A randomized, double-blind, placebo-controlled trial of a novel product
- Incidence of serious infectious events with methotrexate treatment: Metaanalysis of randomized controlled trials
- Reply to: Is melatonin useful in alopecia: critical appraisal of a randomized trial?
- Results of stage I in a phase II randomized bilateral comparison of bexarotene 1% topical gel in alopecia areata
- Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças * Therapy of alopecia areata with topical corticosteroid: prospective double-blind controlled assay in children *
- Efficacy of low-level laser therapy in androgenetic alopecia – A randomized controlled trial
- Efficacy of platelet-rich plasma in Asians with androgenetic alopecia: A randomized controlled trial
- Effects of photobiomodulation therapy for androgenic alopecia: A meta-analysis of randomized controlled trials
- Efficacy and safety of combination therapy in androgenetic alopecia: Randomized uncontrolled evaluator blind study
- Comparison of the efficacy of niosomal minoxidil with conventional minoxidil in the treatment of androgenetic alopecia: A randomized, controlled, double-blind clinical trial
- P111 : Low-Level light therapy in the treatment of androgenetic alopecia: A 24-week, randomized, double-blind, sham device-controlled multicenter trial
- Tratamento da alopecia areata com corticóide tópico: estudo prospectivo randomizado duplo cego em crianças
- A double blind, randomised, vehicle-controlled, safety and tolerance study of topical PSK 3841 solution at 5% administered twice daily over four weeks to healthy Caucasian males with androgenetic alopecia
- Comment on “Association Between Androgenic Alopecia and Schizophrenia: A Bidirectional Mendelian Randomization Study”
- Causal Relationship Between Gut Microbiota and Androgenic Alopecia: A Mendelian Randomization Analysis
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double‐blind placebo‐controlled trial
- Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>)
- Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
- Efficacy of platelet-rich plasma in the treatment of androgenetic (male-patterned) alopecia: A pilot randomized controlled trial
- Inhibition of β-Catenin Signaling in the Skin Rescues Cutaneous Adipogenesis in Systemic Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial of C-82
- The effect of autologous activated platelet-rich plasma injection on female pattern hair loss: A randomized placebo-controlled study
- Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate
- Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study